Menu
Healthy helpful, trendy holiday gifts

Healthy helpful, trendy holiday gif…

Looking for some special ...

10 hot chocolate recipes

10 hot chocolate recipes

Hot chocolate is a classi...

PureWow stylish gifts

PureWow stylish gifts

Here are the holiday seas...

France wins sustainability prize

France wins sustainability prize

If you hadn't heard, Fran...

Best chocolate chip cookie ever?

Best chocolate chip cookie ever?

A pastry chef, a cannabis...

Food lover stocking stuffers

Food lover stocking stuffers

The office secret Santa. ...

2018: The year of purple

2018: The year of purple

We interrupt your daily n...

Hi-tech kitchen gifts

Hi-tech kitchen gifts

Nothing beats unwrapping ...

Prev Next
Restaurant lunch highlights:

'Startling' cancer therapy results

'Startling' cancer therapy results

The 86 cancer patients were a disparate group, with tumors of the pancreas, prostate, uterus or bone. One woman had a cancer so rare there were no tested treatments. She was told to get her affairs in order.

All the patients carried genetic mutations that disrupted the ability of cells to fix damaged DNA. And all were enrolled in a trial of a drug that helps the immune system attack tumors.

The results, published on Thursday in the journal Science, are so striking that the Food and Drug Administration already has approved the drug,
Just 4 percent of cancer patients have the type of genetic aberration susceptible to pembrolizumab. But that adds up to a lot of patients: as many as 60,000 each year in the United States alone, the study's investigators estimated.

As reported on the New York Times website - READ MORE

Last modified onWednesday, 14 June 2017 05:56
back to top